Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus

Buyukhatipoglu, Hakan; Buyukaslan, Hasan; Pehlivan, YAVUZ; Ceylan, Nurdan; Ulas, Turgay; Tarakcioglu, Mehmet; Onat, Ahmet

doi:10.1111/j.1756-185x.2011.01597.x

Increased urotensin-II activity in patients with Raynaud's phenomenon and systemic lupus erythematosus

Buyukhatipoglu H., Buyukaslan H., Pehlivan Y., Ceylan N., Ulas T., Tarakcioglu M., ...Daha Fazla

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, cilt.14, sa.3, ss.276-281, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 14 Sayı: 3
Basım Tarihi: 2011
Doi Numarası: 10.1111/j.1756-185x.2011.01597.x
Dergi Adı: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.276-281
Bursa Uludağ Üniversitesi Adresli: Hayır

Özet

Aim: Raynaud's phenomenon (RP) commonly co-exists with systemic lupus erythematosus (SLE). The obvious pathophysiological mechanism in RP is vasoconstriction. Although the roles of certain vasoconstrictor substances, like endothelin-1, have been identified in RP, underlying mechanisms remain unclear.